1st annual Intellectual Property Rights in the Biotech Industry

7 June 2005 / Radisson SAS Scandinavia Hotel / Copenhagen / Denmark

This is a follow-up event based on the successful Intellectual Intellectual Property Rights conference held last year in Copenhagen. This year’s patent conference will focus on the role of patent enforcement programmes to extend the life cycle of your patents.

Life sciences are a dynamic industry driven by innovation to cure human’s health. Both big pharmaceuticals and small biotech companies need to have a patent enforcement strategy to improve the original innovation in order to stay ahead of your competitors. A patent has a limited life cycle of 20 years from the date of application. It gives the patent owner the legal rights to prevent others practising the claims of your biotech innovations.

A strong IPR strategy that combines both pro-active patent enforcement and patent life cycle management strategies ensures your company further growth and inventions in a highly competitive business environment, the Life Sciences industry.

This international one day-conference presents cutting edge companies from Cambridge Antibody Technology, Novozymes and Simmons & Simmons uncovering first hand experiences to tackle key issues such as develop pro-active patent enforcement strategies to extend product life cycles, current strategies to protect antibodies and how to minimise disruption to your business through patent litigation issues.

NB! Members of Medicon Valley Academy will receive an exclusive 15% discount on the conference fee.

See program (pdf)

For further information, please visit: www.labinnovator.com/events-ipr2005.htm